Dr. Adeleh Yarmohammadi, MD

Dr. Yarmohammadi practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Yarmohammadi's NPI, 1023542370, was assigned on April 13, 2017. Dr. Yarmohammadi graduated from Shahid Beheshti University of Medical Sciences in 2012. Dr. Yarmohammadi holds California license A165699.

Dr. Yarmohammadi's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Yarmohammadi's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Yarmohammadi is also affiliated with Providence Saint John's Health Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Yarmohammadi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yarmohammadi practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Yarmohammadi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Yarmohammadi is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Yarmohammadi is licensed in California.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Yarmohammadi treats.

CMS data shows 831 Medicare services from Dr. Yarmohammadi across 15 procedure codes in 2024, for 279 Medicare patients. Medicare paid $91,761 for them. Every service was in an office.

CMS counts 279 Medicare patients who saw Dr. Yarmohammadi in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yarmohammadi's median patient age at 70, with 59% women.

In 2024, Dr. Yarmohammadi wrote 378 Medicare Part D claims for 132 patients. 57% of them were for generic drugs. CMS names the drug for 296 of them, across 10 drugs with 11 or more claims each, at $14,894 in total drug cost. In 2023, CMS named 339 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Yarmohammadi for performance year 2024, reported individually. Dr. Yarmohammadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of melanoma (skin cancer) excision by Dr. Yarmohammadi, more than 76% of the clinicians it reports for that procedure.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 44 papers to Dr. Yarmohammadi, published from 2016 to 2023. 2017 was the busiest year, with 4. The most frequent topics are Tomography, Optical Coherence, Intraocular Pressure and Glaucoma, Open-Angle. Dr. Yarmohammadi has published most often in Ophthalmology. Dr. Yarmohammadi's most frequent co-authors are Robert N. Weinreb, MD, Felipe Andrade Medeiros, MD and Jeffrey M. Liebmann, MD.

CMS Open Payments shows 63 general payments to Dr. Yarmohammadi from 11 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 90% of the total. Alcon Laboratories Inc paid the most, $955.

Dr. Yarmohammadi graduated from Shahid Beheshti University of Medical Sciences in 2012. Dr. Yarmohammadi is a member of AAO and American Society of Cataract and Refractive Surgery.

Dr. Yarmohammadi is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.